Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Daugaard

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Human Reproduction (Oxford, England)|July 5, 2021
Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapyL Priskorn, M Kreiberg, M Bandak, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1987
The renal handling of sodium and water is not affected by the standard-dose cisplatin treatment for testicular cancerG Daugaard, S Strandgaard, N H Holstein-Rathlou, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2017
Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivorsM Bandak, N Jørgensen, A Juul, et al.
Andrology|July 8, 2018
Quantification of the Leydig cell compartment in testicular biopsies and association with biochemical Leydig cell dysfunction in testicular cancer survivorsM G Tarsitano, M Bandak, N Jørgensen, et al.
Andrology|February 26, 2015
Increasing international efforts to understand and conquer testicular germ cell cancerE Rajpert-De Meyts, G Daugaard, K Almstrup, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development GroupC J A Punt, M J A de Jonge, S Monfardini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry StudyC Oing, K Oechsle, A Necchi, et al.
Andrology|March 25, 2016
Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysisM Bandak, N Jørgensen, A Juul, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
Magnesium depletion enhances cisplatin-induced nephrotoxicityH Lajer, M Kristensen, H H Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysisB M Fischer, J Mortensen, S W Langer, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Human Reproduction (Oxford, England)|July 5, 2021
Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapyL Priskorn, M Kreiberg, M Bandak, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1987
The renal handling of sodium and water is not affected by the standard-dose cisplatin treatment for testicular cancerG Daugaard, S Strandgaard, N H Holstein-Rathlou, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2017
Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivorsM Bandak, N Jørgensen, A Juul, et al.
Andrology|July 8, 2018
Quantification of the Leydig cell compartment in testicular biopsies and association with biochemical Leydig cell dysfunction in testicular cancer survivorsM G Tarsitano, M Bandak, N Jørgensen, et al.
Andrology|February 26, 2015
Increasing international efforts to understand and conquer testicular germ cell cancerE Rajpert-De Meyts, G Daugaard, K Almstrup, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development GroupC J A Punt, M J A de Jonge, S Monfardini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry StudyC Oing, K Oechsle, A Necchi, et al.
Andrology|March 25, 2016
Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysisM Bandak, N Jørgensen, A Juul, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
Magnesium depletion enhances cisplatin-induced nephrotoxicityH Lajer, M Kristensen, H H Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysisB M Fischer, J Mortensen, S W Langer, et al.
Pageof 10